Empirical Wealth Management’s Aclaris Therapeutics ACRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-16,072
Closed -$85K – 1156
2026
Q2
$85K Buy
+16,072
New +$71.7K ﹤0.01% 1045

Other funds holding ACRS

Empirical Wealth Management's ACRS Position: Q3 2026 in Review

Empirical Wealth Management sold out of Aclaris Therapeutics (ACRS) in Q3 2026, closing a stake of 16,072 shares — an estimated $85K sold.

Empirical Wealth Management first reported a position in ACRS in Q2 2026 and held it in 1 quarter. The position peaked at $85K in Q2 2026. 166 funds tracked by Wall St. Rank hold ACRS as of Q3 2026.

  • Empirical Wealth Management reported no remaining Aclaris Therapeutics position as of Q3 2026 after selling out during the quarter.
  • Empirical Wealth Management sold 16,072 Aclaris Therapeutics shares in Q3 2026, an estimated $85K.
  • Empirical Wealth Management first reported a position in Aclaris Therapeutics in Q2 2026 and held it in 1 quarter.
  • Empirical Wealth Management's Aclaris Therapeutics position peaked at $85K in Q2 2026.
  • 166 funds tracked by Wall St. Rank held Aclaris Therapeutics as of Q3 2026.

Based on Empirical Wealth Management's 13F filing for Q3 2026, filed 27 Oct 2026.